Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	estrogen response element binding	NR3C2 AR PGR	7.89e-06	11	74	3	GO:0034056
GeneOntologyMolecularFunction	nuclear receptor activity	NR1H3 NR3C2 AR PGR	7.24e-05	60	74	4	GO:0004879
GeneOntologyMolecularFunction	ligand-activated transcription factor activity	NR1H3 NR3C2 AR PGR	7.73e-05	61	74	4	GO:0098531
GeneOntologyMolecularFunction	steroid binding	GPR155 NR1H3 NR3C2 AR PGR	1.35e-04	133	74	5	GO:0005496
GeneOntologyMolecularFunction	histone H3 demethylase activity	KDM3A KDM2A JMJD1C	1.50e-04	28	74	3	GO:0141052
GeneOntologyMolecularFunction	methyl-CpG binding	MBD1 CXXC4 TET3	2.04e-04	31	74	3	GO:0008327
GeneOntologyMolecularFunction	histone demethylase activity	KDM3A KDM2A JMJD1C	2.04e-04	31	74	3	GO:0032452
GeneOntologyMolecularFunction	protein demethylase activity	KDM3A KDM2A JMJD1C	2.24e-04	32	74	3	GO:0140457
GeneOntologyMolecularFunction	zinc ion binding	LIG3 MBD1 KAT6A CXXC4 NR1H3 KDM2A NR3C2 ZCCHC7 TET3 AR PGR	4.19e-04	891	74	11	GO:0008270
GeneOntologyMolecularFunction	dioxygenase activity	KDM3A KDM2A TET3 JMJD1C	4.82e-04	98	74	4	GO:0051213
GeneOntologyMolecularFunction	demethylase activity	KDM3A KDM2A JMJD1C	5.80e-04	44	74	3	GO:0032451
GeneOntologyMolecularFunction	unmethylated CpG binding	MBD1 KDM2A	5.98e-04	10	74	2	GO:0045322
GeneOntologyMolecularFunction	beta-catenin binding	PTPRU AR CXADR AXIN2	1.03e-03	120	74	4	GO:0008013
GeneOntologyMolecularFunction	transcription coactivator binding	NR3C2 AR PGR	1.06e-03	54	74	3	GO:0001223
GeneOntologyMolecularFunction	histone H3K9 demethylase activity	KDM3A JMJD1C	1.20e-03	14	74	2	GO:0032454
GeneOntologyMolecularFunction	transition metal ion binding	KDM3A LIG3 MBD1 KAT6A CXXC4 NR1H3 KDM2A NR3C2 ZCCHC7 TET3 AR PGR	1.34e-03	1189	74	12	GO:0046914
GeneOntologyMolecularFunction	histone modifying activity	KDM3A KAT6A KDM2A ATM JMJD1C	1.61e-03	229	74	5	GO:0140993
GeneOntologyMolecularFunction	2-oxoglutarate-dependent dioxygenase activity	KDM3A KDM2A TET3	1.81e-03	65	74	3	GO:0016706
Domain	Znf_CXXC	MBD1 CXXC4 KDM2A	9.24e-06	11	73	3	IPR002857
Domain	ZF_CXXC	MBD1 CXXC4 KDM2A	9.24e-06	11	73	3	PS51058
Domain	zf-CXXC	MBD1 CXXC4 KDM2A	9.24e-06	11	73	3	PF02008
Domain	zf-C4	NR1H3 NR3C2 AR PGR	3.10e-05	46	73	4	PF00105
Domain	Znf_hrmn_rcpt	NR1H3 NR3C2 AR PGR	3.10e-05	46	73	4	IPR001628
Domain	NUCLEAR_REC_DBD_2	NR1H3 NR3C2 AR PGR	3.10e-05	46	73	4	PS51030
Domain	NUCLEAR_REC_DBD_1	NR1H3 NR3C2 AR PGR	3.10e-05	46	73	4	PS00031
Domain	ZnF_C4	NR1H3 NR3C2 AR PGR	3.10e-05	46	73	4	SM00399
Domain	-	NR1H3 NR3C2 AR PGR	3.37e-05	47	73	4	1.10.565.10
Domain	HOLI	NR1H3 NR3C2 AR PGR	3.67e-05	48	73	4	SM00430
Domain	Nucl_hrmn_rcpt_lig-bd	NR1H3 NR3C2 AR PGR	3.67e-05	48	73	4	IPR000536
Domain	Hormone_recep	NR1H3 NR3C2 AR PGR	3.67e-05	48	73	4	PF00104
Domain	-	NR1H3 NR3C2 AR PGR	7.25e-05	57	73	4	3.30.50.10
Domain	Znf_NHR/GATA	NR1H3 NR3C2 AR PGR	7.77e-05	58	73	4	IPR013088
Domain	JmjC	KDM3A KDM2A JMJD1C	1.09e-04	24	73	3	PF02373
Domain	zf-RING_9	RUBCNL PLEKHM3	1.50e-04	5	73	2	PF13901
Domain	DUF4206	RUBCNL PLEKHM3	1.50e-04	5	73	2	SM01175
Domain	Zf-RING_9	RUBCNL PLEKHM3	1.50e-04	5	73	2	IPR025258
Domain	JMJC	KDM3A KDM2A JMJD1C	2.62e-04	32	73	3	PS51184
Domain	JmjC_dom	KDM3A KDM2A JMJD1C	2.62e-04	32	73	3	IPR003347
Domain	Znf_FYVE_PHD	KDM3A PHF23 KAT6A KDM2A DNMT3B	2.76e-04	147	73	5	IPR011011
Domain	JmjC	KDM3A KDM2A JMJD1C	2.87e-04	33	73	3	SM00558
Domain	BRCT	LIG3 BARD1	3.31e-03	22	73	2	SM00292
Domain	-	LIG3 BARD1	3.61e-03	23	73	2	3.40.50.10190
Domain	Znf_PHD-finger	PHF23 KAT6A KDM2A	3.66e-03	79	73	3	IPR019787
Domain	BRCT	LIG3 BARD1	4.61e-03	26	73	2	PS50172
Domain	PHD	PHF23 KAT6A KDM2A	5.11e-03	89	73	3	SM00249
Domain	BRCT_dom	LIG3 BARD1	5.33e-03	28	73	2	IPR001357
Domain	Znf_PHD	PHF23 KAT6A KDM2A	5.44e-03	91	73	3	IPR001965
Domain	ZF_PHD_2	PHF23 KAT6A KDM2A	6.13e-03	95	73	3	PS50016
Domain	ZF_PHD_1	PHF23 KAT6A KDM2A	6.31e-03	96	73	3	PS01359
Pathway	REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS	NR1H3 NR3C2 AR PGR	4.91e-06	28	58	4	MM15042
Pathway	REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS	NR1H3 NR3C2 AR PGR	6.53e-06	30	58	4	M27323
Pathway	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	NR1H3 NR3C2 AR PGR	4.39e-05	48	58	4	MM14987
Pathway	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	NR1H3 NR3C2 AR PGR	6.50e-05	53	58	4	M8276
Pathway	REACTOME_SUMOYLATION	MBD1 NR1H3 NR3C2 AR PGR DNMT3B	6.56e-05	169	58	6	MM14919
Pathway	REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR	UBA52 BARD1 ATM SPIDR	9.92e-05	59	58	4	MM15283
Pathway	REACTOME_HOMOLOGY_DIRECTED_REPAIR	LIG3 UBA52 BARD1 ATM SPIDR	1.12e-04	116	58	5	MM15294
Pathway	REACTOME_SUMOYLATION	MBD1 NR1H3 NR3C2 AR PGR DNMT3B	1.22e-04	189	58	6	M27214
Pathway	REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR	UBA52 BARD1 ATM SPIDR	1.93e-04	70	58	4	M27570
Pathway	REACTOME_DNA_REPAIR	LIG3 UBA52 ERCC2 UVSSA BARD1 ATM SPIDR	2.23e-04	301	58	7	MM15433
Pathway	REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER	LIG3 UBA52 ERCC2 UVSSA	2.52e-04	75	58	4	MM15316
Pathway	REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER	LIG3 UBA52 ERCC2 UVSSA	2.65e-04	76	58	4	M27600
Pathway	REACTOME_HOMOLOGY_DIRECTED_REPAIR	LIG3 UBA52 BARD1 ATM SPIDR	2.70e-04	140	58	5	M27584
Pathway	PID_BETA_CATENIN_NUC_PATHWAY	DKK1 SP5 AR AXIN2	3.23e-04	80	58	4	M223
Pathway	REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR	LIG3 UBA52 BARD1 ATM SPIDR	3.28e-04	146	58	5	MM15292
Pathway	REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES	BARD1 ATM SPIDR	3.94e-04	35	58	3	MM15293
Pathway	REACTOME_DNA_REPAIR	LIG3 UBA52 ERCC2 UVSSA BARD1 ATM SPIDR	4.04e-04	332	58	7	M15434
Pathway	REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES	BARD1 ATM SPIDR	4.65e-04	37	58	3	M27583
Pathway	WP_NUCLEAR_RECEPTORS	NR1H3 AR PGR	5.03e-04	38	58	3	M39657
Pathway	WP_NUCLEAR_RECEPTORS	NR1H3 AR PGR	5.03e-04	38	58	3	MM15865
Pathway	REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR	LIG3 UBA52 BARD1 ATM SPIDR	6.57e-04	170	58	5	M27582
Pathway	REACTOME_PEXOPHAGY	UBA52 ATM	8.93e-04	11	58	2	M29846
Pathway	REACTOME_PEXOPHAGY	UBA52 ATM	8.93e-04	11	58	2	MM15673
Pathway	REACTOME_NUCLEOTIDE_EXCISION_REPAIR	LIG3 UBA52 ERCC2 UVSSA	1.01e-03	108	58	4	M7927
Pathway	REACTOME_NUCLEOTIDE_EXCISION_REPAIR	LIG3 UBA52 ERCC2 UVSSA	1.01e-03	108	58	4	MM15304
Pubmed	DNA Sequence Recognition of Human CXXC Domains and Their Structural Determinants.	MBD1 CXXC4 KDM2A TET3	4.15e-09	10	75	4	29276034
Pubmed	Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.	LIG3 ERCC2 BARD1 ATM AR PGR DNMT3B	8.84e-08	170	75	7	19064572
Pubmed	Wnt3 function in the epiblast is required for the maintenance but not the initiation of gastrulation in mice.	DKK1 SP5 AXIN2	8.02e-07	9	75	3	23085236
Pubmed	Celastrol recruits UBE3A to recognize and degrade the DNA binding domain of steroid receptors.	NR3C2 AR PGR	1.14e-06	10	75	3	36109631
Pubmed	A complex oscillating network of signaling genes underlies the mouse segmentation clock.	DKK1 SP5 GFRA2 AXIN2	1.25e-06	37	75	4	17095659
Pubmed	Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1.	NR3C2 AR PGR	2.71e-06	13	75	3	9115274
Pubmed	Identification of Jmjd3 as an Essential Epigenetic Regulator of Hox Gene Temporal Collinear Activation for Body Axial Patterning in Mice.	COL2A1 KDM3A KDM2A JMJD1C	3.93e-06	49	75	4	34368113
Pubmed	Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors.	NR3C2 AR PGR	4.30e-06	15	75	3	20661446
Pubmed	TET2 catalyzes active DNA demethylation of the Sry promoter and enhances its expression.	KDM3A TET3 DNMT3B	4.30e-06	15	75	3	31530896
Pubmed	DNMT3B attenuated the inhibition of TET3 on epithelial-mesenchymal transition in TGF-β1-induced ovarian cancer by methylating the TET3 promoter.	TET3 DNMT3B	4.59e-06	2	75	2	36242939
Pubmed	ATM Inhibition Potentiates Death of Androgen Receptor-inactivated Prostate Cancer Cells with Telomere Dysfunction.	ATM AR	4.59e-06	2	75	2	26336104
Pubmed	The androgen and progesterone receptors regulate distinct gene networks and cellular functions in decidualizing endometrium.	AR PGR	4.59e-06	2	75	2	18511503
Pubmed	The UVSSA protein is part of a genome integrity homeostasis network with links to transcription-coupled DNA repair and ATM signaling.	UVSSA ATM	4.59e-06	2	75	2	35254895
Pubmed	Intrinsic and extrinsic connections of Tet3 dioxygenase with CXXC zinc finger modules.	CXXC4 TET3	4.59e-06	2	75	2	23690950
Pubmed	Prostaglandin treatment is associated with a withdrawal of progesterone and androgen at the receptor level in the uterine cervix.	AR PGR	4.59e-06	2	75	2	19852793
Pubmed	The metabolic fate and receptor interaction of 16α-hydroxyprogesterone and its 5α-reduced metabolite, 16α-hydroxy-dihydroprogesterone.	AR PGR	4.59e-06	2	75	2	27664517
Pubmed	Interdomain interactions in the mineralocorticoid receptor.	NR3C2 AR	4.59e-06	2	75	2	12644298
Pubmed	Glucocorticoid and mineralocorticoid cross-talk with progesterone receptor to induce focal adhesion and growth inhibition in breast cancer cells.	NR3C2 PGR	4.59e-06	2	75	2	14617569
Pubmed	Imbalance hepatic metabolism homeostasis in the F1 generation of endometrial DNMT3B conditional knockout female mice.	PGR DNMT3B	4.59e-06	2	75	2	36439251
Pubmed	Efficient mitosis in human cells lacking poleward microtubule flux.	KIF2A KIF2C	4.59e-06	2	75	2	16243029
Pubmed	Some mutations in the xeroderma pigmentosum D gene may lead to moderate but significant radiosensitivity associated with a delayed radiation-induced ATM nuclear localization.	ERCC2 ATM	4.59e-06	2	75	2	31738647
Pubmed	Blood cellular mutant LXR-α protein stability governs initiation of coronary heart disease.	BARD1 NR1H3	4.59e-06	2	75	2	24009820
Pubmed	Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations.	AR PGR	4.59e-06	2	75	2	10840043
Pubmed	Expression of Progesterone and Androgen Receptors in the Breast of Premenopausal Women, Considering Menstrual Phase.	AR PGR	4.59e-06	2	75	2	29491078
Pubmed	Uterine deficiency of Dnmt3b impairs decidualization and causes consequent embryo implantation defects.	PGR DNMT3B	4.59e-06	2	75	2	34773530
Pubmed	Intrinsic mitochondrial DNA repair defects in Ataxia Telangiectasia.	LIG3 ATM	4.59e-06	2	75	2	24342190
Pubmed	The KinI kinesin Kif2a is required for bipolar spindle assembly through a functional relationship with MCAK.	KIF2A KIF2C	4.59e-06	2	75	2	15302853
Pubmed	Prenatal androgenization causes expression changes of progesterone and androgen receptor mRNAs in the arcuate nucleus of female mice across development.	AR PGR	4.59e-06	2	75	2	34748236
Pubmed	Functional proteomics mapping of a human signaling pathway.	PPP1R26 RALA UBA52 RNF123 DKK1 MACO1 MBD1 KDM2A ZCCHC7	5.15e-06	591	75	9	15231748
Pubmed	Multiplex rt-PCR expression analysis of developmentally important genes in individual mouse preimplantation embryos and blastomeres.	LIG3 MBD1 DNMT3B	5.29e-06	16	75	3	18784354
Pubmed	Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array.	LIG3 ERCC2 BARD1 ATM	6.26e-06	55	75	4	19536092
Pubmed	Expression and functional analysis of Dkk1 during early gonadal development.	DKK1 SP5 AXIN2	6.41e-06	17	75	3	21654186
Pubmed	A Large-scale genetic association study of esophageal adenocarcinoma risk.	LIG3 ERCC2 BARD1 ATM PGR AXIN2 DNMT3B	1.11e-05	351	75	7	20453000
Pubmed	Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer.	AR PGR	1.37e-05	3	75	2	19147544
Pubmed	Increase and Redistribution of Sex Hormone Receptors in Premenopausal Women Are Associated with Varicose Vein Remodelling.	AR PGR	1.37e-05	3	75	2	30250632
Pubmed	Liver X receptor ligands suppress ubiquitination and degradation of LXRalpha by displacing BARD1/BRCA1.	BARD1 NR1H3	1.37e-05	3	75	2	19164445
Pubmed	Transgenic introduction of androgen receptor into estrogen-receptor-, progesterone-receptor-, and androgen-receptor-negative breast cancer cells renders them responsive to hormonal manipulation.	AR PGR	1.37e-05	3	75	2	16647340
Pubmed	Expression patterns of sex steroid receptors in developing mesonephros of the male mouse: three-dimensional analysis.	AR PGR	1.37e-05	3	75	2	37335379
Pubmed	ATM gene variants in patients with idiopathic perifoveal telangiectasia.	ATM CFB	1.37e-05	3	75	2	18502988
Pubmed	Monogenic and polygenic determinants of sarcoma risk: an international genetic study.	ERCC2 ATM	1.37e-05	3	75	2	27498913
Pubmed	Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex.	AR PGR	1.37e-05	3	75	2	27690341
Pubmed	CpG islands aberrant hypermethylation of sex hormone receptor superfamily might be involved in the development of leukemic neoplasms.	AR PGR	1.37e-05	3	75	2	20299092
Pubmed	Ras transformation uncouples the kinesin-coordinated cellular nutrient response.	KIF2A KIF2C	1.37e-05	3	75	2	25002494
Pubmed	Tectorins crosslink type II collagen fibrils and connect the tectorial membrane to the spiral limbus.	COL2A1 TECTB	1.37e-05	3	75	2	26806019
Pubmed	LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1.	DKK1 AXIN2	1.37e-05	3	75	2	23302695
Pubmed	Human bleomycin hydrolase binds ribosomal proteins.	RPL29 RPL11	1.37e-05	3	75	2	10353821
Pubmed	The kinesin-13 proteins Kif2a, Kif2b, and Kif2c/MCAK have distinct roles during mitosis in human cells.	KIF2A KIF2C	1.37e-05	3	75	2	17538014
Pubmed	Investigation of hormone receptor genes in migraine.	AR PGR	1.37e-05	3	75	2	15654614
Pubmed	Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells.	KIF2A KIF2C	1.37e-05	3	75	2	24240690
Pubmed	The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily.	AR PGR	1.37e-05	3	75	2	9891052
Pubmed	Identification and validation of mRNA 3'untranslated regions of DNMT3B and TET3 as novel competing endogenous RNAs of the tumor suppressor PTEN.	TET3 DNMT3B	1.37e-05	3	75	2	31894272
Pubmed	Human ketosteroid receptors interact with hazardous phthalate plasticizers and their metabolites: an in silico study.	AR PGR	1.37e-05	3	75	2	26304264
Pubmed	The pattern of beta-catenin responsiveness within the mammary gland is regulated by progesterone receptor.	PGR AXIN2	1.37e-05	3	75	2	17881490
Pubmed	Glandular epithelial AR inactivation enhances PTEN deletion-induced uterine pathology.	AR PGR	1.37e-05	3	75	2	26984887
Pubmed	Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome.	AR PGR	1.37e-05	3	75	2	19458022
Pubmed	Nuclear receptors in Leydig cell gene expression and function.	NR1H3 AR PGR	1.44e-05	22	75	3	20375256
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	LIG3 RPL29 MACO1 MBD1 BARD1 BEND3 KDM2A ZCCHC7 TET3 JMJD1C RPL11 KIF2C	2.00e-05	1294	75	12	30804502
Pubmed	Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non-small-cell lung cancer.	LIG3 ERCC2 ATM	2.42e-05	26	75	3	20731661
Pubmed	Gain in transcriptional activity by primate-specific coevolution of melanoma antigen-A11 and its interaction site in androgen receptor.	AR PGR	2.75e-05	4	75	2	21730049
Pubmed	Protein complex interactor analysis and differential activity of KDM3 subfamily members towards H3K9 methylation.	KDM3A JMJD1C	2.75e-05	4	75	2	23593242
Pubmed	Sex-dependent expression of prostatic markers and hormone receptors in cystic tumor of the atrioventricular node: A histopathological study of three cases.	AR PGR	2.75e-05	4	75	2	33316142
Pubmed	Analysis of human syndromes with disordered chromatin reveals the impact of heterochromatin on the efficacy of ATM-dependent G2/M checkpoint arrest.	ATM DNMT3B	2.75e-05	4	75	2	21791604
Pubmed	Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.	ATM AR	2.75e-05	4	75	2	26928463
Pubmed	A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis.	AR PGR	2.75e-05	4	75	2	19555469
Pubmed	Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer.	SP5 AXIN2	2.75e-05	4	75	2	24609463
Pubmed	A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients.	RUBCNL EPB41L3	2.75e-05	4	75	2	21796628
Pubmed	Phylogenetic analyses reveal ancient duplication of estrogen receptor isoforms.	AR PGR	2.75e-05	4	75	2	10552042
Pubmed	JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor.	KDM3A AR	2.75e-05	4	75	2	16603237
Pubmed	Expression profile and prognostic role of sex hormone receptors in gastric cancer.	AR PGR	2.75e-05	4	75	2	23199240
Pubmed	Novel ATPase of SNF2-like protein family interacts with androgen receptor and modulates androgen-dependent transcription.	AR PGR	2.75e-05	4	75	2	12058073
Pubmed	Repressors of androgen and progesterone receptor action.	AR PGR	2.75e-05	4	75	2	12771131
Pubmed	Successful therapeutic intervention in new mouse models of frizzled 2-associated congenital malformations.	DKK1 AXIN2	2.75e-05	4	75	2	36789910
Pubmed	Ovarian cancer and polymorphisms in the androgen and progesterone receptor genes: a HuGE review.	AR PGR	2.75e-05	4	75	2	14769635
Pubmed	Fgfr2b mediated epithelial-mesenchymal interactions coordinate tooth morphogenesis and dental trigeminal axon patterning.	DKK1 PLXNA4 AXIN2	3.04e-05	28	75	3	17951031
Pubmed	The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer.	ATM AR PGR	3.38e-05	29	75	3	19094228
Pubmed	Genetic susceptibility to distinct bladder cancer subphenotypes.	LIG3 ERCC2 BARD1 ATM AR PGR AXIN2	3.54e-05	421	75	7	19692168
Pubmed	Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.	AR PGR	4.57e-05	5	75	2	19739075
Pubmed	Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation.	RPL29 RPL11	4.57e-05	5	75	2	20554519
Pubmed	Telomere-Internal Double-Strand Breaks Are Repaired by Homologous Recombination and PARP1/Lig3-Dependent End-Joining.	LIG3 ATM	4.57e-05	5	75	2	27806302
Pubmed	Hormone receptors expression in phyllodes tumors of the breast.	AR PGR	4.57e-05	5	75	2	22590818
Pubmed	Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription.	AR PGR	4.57e-05	5	75	2	9710597
Pubmed	Association of endometriosis risk and genetic polymorphisms involving sex steroid biosynthesis and their receptors: a meta-analysis.	AR PGR	4.57e-05	5	75	2	16244490
Pubmed	Dickkopf-1 promotes hematopoietic regeneration via direct and niche-mediated mechanisms.	DKK1 AXIN2	4.57e-05	5	75	2	27918563
Pubmed	BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage.	BARD1 ATM	4.57e-05	5	75	2	15159397
Pubmed	Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.	BARD1 ATM	4.57e-05	5	75	2	28418444
Pubmed	Association study of gender identity disorder and sex hormone-related genes.	AR PGR	4.57e-05	5	75	2	19604497
Pubmed	A novel variant of the putative demethylase gene, s-JMJD1C, is a coactivator of the AR.	JMJD1C AR	4.57e-05	5	75	2	17353003
Pubmed	High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells.	AR PGR	4.57e-05	5	75	2	9671457
Pubmed	Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation.	ERCC2 AR	4.57e-05	5	75	2	11266437
Pubmed	Canonical Wnt signaling regulates the proliferative expansion and differentiation of fibrocytes in the murine inner ear.	COL2A1 SP5 AXIN2	5.02e-05	33	75	3	24727668
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	LIG3 BARD1 BEND3 KIF2A ATM JMJD1C KIF2C	5.62e-05	453	75	7	29656893
Pubmed	Ovarian development in mice requires the GATA4-FOG2 transcription complex.	DKK1 SP5 AXIN2	6.53e-05	36	75	3	18927154
Pubmed	Synergistic induction of follicle-stimulating hormone beta-subunit gene expression by gonadal steroid hormone receptors and Smad proteins.	AR PGR	6.84e-05	6	75	2	18079204
Pubmed	SNP-SNP interactions in breast cancer susceptibility.	ERCC2 BARD1	6.84e-05	6	75	2	16672066
Pubmed	Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity.	ERCC2 ATM	6.84e-05	6	75	2	20170971
Pubmed	Characterisation of the Wnt antagonists and their response to conditionally activated Wnt signalling in the developing mouse forebrain.	DKK1 AXIN2	6.84e-05	6	75	2	15527894
Pubmed	Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population.	AR PGR	6.84e-05	6	75	2	18483761
Pubmed	Genome instability and embryonic developmental defects in RMI1 deficient mice.	ATM AXIN2	6.84e-05	6	75	2	23900276
Pubmed	Exploring the formation mechanism of short-tailed phenotypes in animals using mutant mice with the TBXT gene c.G334T developed by CRISPR/Cas9.	DKK1 AXIN2	6.84e-05	6	75	2	38401832
Pubmed	ATM-mediated KDM2A phosphorylation is required for the DNA damage repair.	KDM2A ATM	6.84e-05	6	75	2	25823024
Cytoband	11q22-q23	ATM PGR	3.93e-05	6	75	2	11q22-q23
Cytoband	7q36.1	GIMAP8 RARRES2 REPIN1	2.50e-04	74	75	3	7q36.1
GeneFamily	Zinc fingers CXXC-type	MBD1 CXXC4 KDM2A TET3	4.63e-08	12	58	4	136
GeneFamily	Nuclear hormone receptors	NR1H3 NR3C2 AR PGR	1.81e-05	49	58	4	71
GeneFamily	PHD finger proteins\|Lysine demethylases	KDM3A KDM2A JMJD1C	6.04e-05	24	58	3	485
GeneFamily	L ribosomal proteins	RPL29 UBA52 RPL11	5.85e-04	51	58	3	729
GeneFamily	Speedy/RINGO cell cycle regulator family	SPDYE7P SPDYE3	6.54e-04	12	58	2	756
GeneFamily	PHD finger proteins	PHF23 KAT6A KDM2A	3.02e-03	90	58	3	88
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#1	DKK1 SPON1 BEND3 PLEKHM3 CXADR DNMT3B	1.07e-05	145	73	6	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K1
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#3	DKK1 SPON1 BEND3 PLEKHM3 CXADR DNMT3B	3.86e-05	182	73	6	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500	DKK1 BACH2 NDP EPB41L3 AR GFRA2 CACNA2D3 AXIN2	5.72e-05	390	73	8	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_200	DKK1 EPB41L3 GFRA2 CACNA2D3	7.43e-05	65	73	4	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200_k5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#2	DKK1 SPON1 BEND3 PLEKHM3 GFRA2 CXADR DNMT3B	8.02e-05	302	73	7	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K2
CoexpressionAtlas	facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1	COL2A1 RPL29 SPON1 BEND3 NLRP1 KIF2A ATM CHST2 ZCCHC7 CXADR AXIN2 KIF2C DNMT3B	1.51e-04	1164	73	13	facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1
CoexpressionAtlas	facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500	COL2A1 RPL29 SPON1 BEND3 NLRP1 KIF2A ATM CHST2 ZCCHC7 AR CXADR AXIN2 KIF2C DNMT3B	1.73e-04	1347	73	14	facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500
CoexpressionAtlas	facebase_RNAseq_e8.5_FloorPlate_2500_K3	RPL29 SEPTIN3 DKK1 SPON1 BARD1 BEND3 NLRP1 KIF2A PLEKHM3 ATM P3H4 CXADR KIF2C DNMT3B	2.08e-04	1371	73	14	facebase_RNAseq_e8.5_FloorPlate_2500_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_200	DKK1 EPB41L3 AR GFRA2 CACNA2D3	2.08e-04	157	73	5	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#4_top-relative-expression-ranked_1000	DKK1 SPON1 CHST2 PTPRU CXADR	2.14e-04	158	73	5	gudmap_developingKidney_e14.5 whole kidney - wildtype_1000_k4
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-SELL+_CD8_T\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPR155 RPL29 UBA52 BACH2 ATM RPL11	7.42e-07	189	74	6	e9f66bf288aac04602206f058f5b7af75b1ffdab
ToppCell	ILEUM-inflamed-(2)_Naive_B_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RPL29 UBA52 BACH2 RUBCNL ZCCHC7 RPL11	7.65e-07	190	74	6	a08d10f8145247d16c952a6f83957f5b57c6940b
ToppCell	11.5-Distal\|11.5 / Age, Tissue, Lineage and Cell class	RPL29 UBA52 RARRES2 DKK1 CHST2 RPL11	8.13e-07	192	74	6	169b9ee2377beb9e4ad35bc82bb7a3dafe8f05b6
ToppCell	B_cell_maturation-Naive_B_cell\|World / Lineage and Cell class	RPL29 SPON1 BACH2 RUBCNL ZCCHC7 RPL11	8.13e-07	192	74	6	58267a11c938a380c6e26f4e4ce63f3b4be79fdc
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-Naive_B\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RPL29 UBA52 BACH2 RUBCNL ZCCHC7 RPL11	8.90e-07	195	74	6	537ca6df3a44bfde83c137f0c808a595c3dad892
ToppCell	Biopsy_Other_PF-Mesenchymal-Mesothelial_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	RARRES2 DKK1 PLXNA4 PSAPL1 CXADR CFB	9.73e-07	198	74	6	86736f01e61bf4961f060b24ee1f1f48340737dd
ToppCell	severe-CD8+_T_naive\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	GPR155 RPL29 BACH2 KIF2A ATM RPL11	1.00e-06	199	74	6	656e639228b3f2dca6955a487e4999e73a69bc51
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RARRES2 BCAM P3H4 CXADR CFB	8.69e-06	167	74	5	c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RARRES2 BCAM P3H4 CXADR CFB	8.69e-06	167	74	5	351f8de1fbdf742ac74f9099b254d515ab539bb2
ToppCell	normal_Lung-Fibroblasts-Mesothelial_cells\|Fibroblasts / Location, Cell class and cell subclass	SPDYE3 BCAM PSAPL1 CXADR CFB	8.69e-06	167	74	5	892a2dc83ab5de5a1016402f8e95d2aabf651326
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-4\|TCGA-Liver / Sample_Type by Project: Shred V9	COL2A1 DKK1 BEND3 BCAM DNMT3B	9.21e-06	169	74	5	0a3ba6b5d6cff9d3d7f56046063cfc3a37ae1156
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DKK1 BRINP2 CXADR CFB AXIN2	9.21e-06	169	74	5	0cece9b2bb1f58e465c20ec8735a4fc3c1021f03
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DKK1 BRINP2 CXADR CFB AXIN2	9.21e-06	169	74	5	6937c46b119d4ce382fc8c2fa5925ede5ae89c81
ToppCell	AT1-AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	WFDC3 DKK1 PSAPL1 CXADR CFB	1.00e-05	172	74	5	0be41df5d35d818deb7316ac21c9366eb4b7bfd1
ToppCell	(2)_NK/T-(23)_CD4+_T_cell-(232)_CD4+/CD45RA+_Naive_T_cell\|(23)_CD4+_T_cell / immune cells in Peripheral Blood (logTPM normalization)	RPL29 UBA52 BACH2 ATM RPL11	1.09e-05	175	74	5	fc40fda0fb9954cb0970c6ac71f6d6df7d27dc5c
ToppCell	IIH-mDC1-\|IIH / Condition, Cell_class and T cell subcluster	SEPTIN3 RUBCNL PLEKHM3 CHST2 GFRA2	1.12e-05	176	74	5	bb80a3e595d071f6cc8b042984b8d9490e377eef
ToppCell	IIH-mDC1\|IIH / Condition, Cell_class and T cell subcluster	SEPTIN3 RUBCNL PLEKHM3 CHST2 GFRA2	1.12e-05	176	74	5	a75dc132a1061006fd1cb305bd314784fca07ea6
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RARRES2 BCAM P3H4 CXADR CFB	1.28e-05	181	74	5	330d4322f4c4373f706273c1f4e218b59051b7fd
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RARRES2 BCAM P3H4 CXADR CFB	1.28e-05	181	74	5	3f4d5d79c1286614514b0e8134079d6128a2a23e
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DKK1 BRINP2 BCAM PSAPL1 CFB	1.35e-05	183	74	5	9d5a363fbe6f0a1668c9d584df65ee1c283349c7
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DKK1 BRINP2 BCAM PSAPL1 CFB	1.35e-05	183	74	5	c5caac6ed6c8d67f5c336281d9fd903976509445
ToppCell	Bac-SEP-Lymphocyte-B-B_naive\|Bac-SEP / Disease, Lineage and Cell Type	SPON1 BACH2 RUBCNL ZCCHC7 RPL11	1.43e-05	185	74	5	4d9e1eeb353c0b1f82f557856e99c8bf04aa2a7f
ToppCell	PBMC-Control\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	RPL29 UBA52 ZDHHC1 RPL11 CACNA2D3	1.50e-05	187	74	5	91464e5b7fa5cca7810b45f41b933d3a5a6e3c95
ToppCell	facs-Heart-LA-24m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPON1 CXXC4 SP5 BCAM PTPRU	1.50e-05	187	74	5	d9943e65eedab73d141eae524e2411653a751705
ToppCell	facs-Heart-LA-24m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPON1 CXXC4 SP5 BCAM PTPRU	1.50e-05	187	74	5	7b13c3b67d66f3afb410141d5471c9e78a4d8623
ToppCell	Healthy_donor-pDC\|World / disease group, cell group and cell class (v2)	SEPTIN3 RARRES2 RUBCNL PLXNA4 AR	1.50e-05	187	74	5	aa2cc54487d3c5045ac0c93560944c5a55878e27
ToppCell	PBMC-Control\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RPL29 UBA52 ZDHHC1 RPL11 CACNA2D3	1.50e-05	187	74	5	b38017ffc87fb04d4e4d3755f729f9c1470bb001
ToppCell	Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Immature_PNs\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	KDM3A RPL29 ZCCHC7 CXADR RPL11	1.58e-05	189	74	5	b9c16823e86b01b96bf96d38224a13b9c856d8ad
ToppCell	10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NR1H3 EPB41L3 GFRA2 CFB PGR	1.62e-05	190	74	5	cf463b2f227f3cc7d3fd296c810c0cbe51cbee72
ToppCell	(4)_B_mantle\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	RPL29 BACH2 RUBCNL ZCCHC7 RPL11	1.66e-05	191	74	5	5dab7f26c59838080787efad963b9cfcfa9a5f13
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DKK1 BRINP2 BCAM PSAPL1 CFB	1.66e-05	191	74	5	5343a527de6b0f852f45020a91f5b4869e78f13a
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DKK1 BRINP2 BCAM PSAPL1 CFB	1.66e-05	191	74	5	a25a5f9a380031fdaf57677a079f97a90f0550c0
ToppCell	ASK454-Epithelial-Secretory\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	RNF123 UVSSA BARD1 CHST2 CXADR	1.66e-05	191	74	5	c63c781e7e93265e591cf494cb4ce8ed797c24fb
ToppCell	Control\|World / Disease condition and Cell class	RPL29 UBA52 ZDHHC1 RPL11 CACNA2D3	1.66e-05	191	74	5	17bc87bc638fd98defdaec908300728dd76b0e8c
ToppCell	PND07\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RPL29 RARRES2 SPON1 CHST2 GFRA2	1.70e-05	192	74	5	8171a60df481195c39a7f740effcae8e4deb6ca7
ToppCell	MS-mDC1\|MS / Condition, Cell_class and T cell subcluster	SEPTIN3 RUBCNL PLEKHM3 CHST2 REPIN1	1.75e-05	193	74	5	4d08ebf555954d6a873a4b4c4d661dc5dd8a5bcb
ToppCell	MS-mDC1-\|MS / Condition, Cell_class and T cell subcluster	SEPTIN3 RUBCNL PLEKHM3 CHST2 REPIN1	1.75e-05	193	74	5	ce873f20b93e3b57c9385ee10d4becebe32ada06
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RARRES2 DKK1 PLXNA4 BRINP2 CFB	1.79e-05	194	74	5	c578cf7c6b4d6f31f87dde8845de5b3891f16822
ToppCell	PND01-03-samps-Mesenchymal\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	RARRES2 SPON1 CHST2 GFRA2 AXIN2	1.79e-05	194	74	5	4f9bd0ded0dde1df885850714f29e73e992539a5
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-B_naive-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RPL29 BACH2 RUBCNL ZCCHC7 RPL11	1.79e-05	194	74	5	a778b5d1f7661c29dc8d894827891c1036255749
ToppCell	mild-Lymphocytic-B_cells_1\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	RPL29 BACH2 RUBCNL ZCCHC7 RPL11	1.79e-05	194	74	5	fad1986cba9cd23ac68e639d7335fbcd6ae2a4e7
ToppCell	LA-05._Cytoplasmic_Cardiomyocyte_I\|LA / Chamber and Cluster_Paper	RPL29 UBA52 RARRES2 CFB RPL11	1.79e-05	194	74	5	e4b3a896e79666a935171af05c8d0b68de4fee32
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibro-meso\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RARRES2 DKK1 PLXNA4 BRINP2 CFB	1.79e-05	194	74	5	f4286ae7bb8350c42d50727ee8688b80129714f6
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RARRES2 DKK1 PLXNA4 BRINP2 CFB	1.79e-05	194	74	5	87461bd6d7f702c0a0f5e0c8ace3049125a51f9a
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RPL29 UBA52 RUBCNL ZCCHC7 RPL11	1.79e-05	194	74	5	dcf1b66f20ee9fe86de71221a086742140aa07d8
ToppCell	ILEUM-inflamed-(2)_B_cell-(2)_Naive_B_cells\|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RPL29 UBA52 BACH2 ZCCHC7 RPL11	1.79e-05	194	74	5	a89e67a40382600739be92e395bf47dd44aa4122
ToppCell	normal_Lung-B_lymphocytes-Follicular_B_cells\|B_lymphocytes / Location, Cell class and cell subclass	RPL29 UBA52 BACH2 ZCCHC7 RPL11	1.84e-05	195	74	5	2a9a2b36a9a4ce72a3b855c0872214f38a7c64b0
ToppCell	ILEUM-non-inflamed-(1)_T_cell-(1)_Naive_T_cells\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RPL29 UBA52 BACH2 ATM RPL11	1.88e-05	196	74	5	eda187f50e1bcf8f9bc9af3ea05c63748d66570a
ToppCell	E17.5-Mesenchymal\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RARRES2 SPON1 NR1H3 CHST2 GFRA2	1.88e-05	196	74	5	b4ee991445b612506372b9361ebfe72cb59b811e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	BACH2 RUBCNL ATM ZCCHC7 RPL11	1.88e-05	196	74	5	c225c8eb2fe9a10f0cf574c7d8b6206887aac2df
ToppCell	normal_Pleural_Fluid-B_lymphocytes-Follicular_B_cells\|B_lymphocytes / Location, Cell class and cell subclass	RPL29 UBA52 BACH2 RUBCNL RPL11	1.88e-05	196	74	5	d9951569068ad346a0764fe3bafff43e9f409992
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RPL29 UBA52 BACH2 ATM RPL11	1.93e-05	197	74	5	f8df99dc9a2c939ec7a99183c1110d56e9c7e19a
ToppCell	COVID-19_Severe-B_naive\|COVID-19_Severe / disease group, cell group and cell class	RPL29 BACH2 RUBCNL ZCCHC7 RPL11	1.93e-05	197	74	5	b8f18b39435e2229ba3bc07a25eb875d1ec11f6f
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature2_(2)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	RPL29 UBA52 RARRES2 CHST2 RPL11	1.98e-05	198	74	5	89e25687b614525548279e5fa293c66f5c4abec3
ToppCell	control-CD8+_T_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	GPR155 RPL29 BACH2 ATM RPL11	1.98e-05	198	74	5	a2c70840c38e9a76543060c112e7d9332dd58a89
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RPL29 UBA52 RARRES2 BCAM RPL11	1.98e-05	198	74	5	3df358e2504c36ce5265e4883a71941df473443f
ToppCell	Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_PNs\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	KDM3A RPL29 UBA52 ZCCHC7 RPL11	1.98e-05	198	74	5	8de1808898e63cd74b131baeb9610e88363a41d1
ToppCell	18-Distal-Epithelial-Bud_tip_progenitor\|Distal / Age, Tissue, Lineage and Cell class	RPL29 SP5 BCAM CXADR RPL11	1.98e-05	198	74	5	fdd3b428483dbca0fc5b1412446a812e8ad616a9
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature2_(2)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	RPL29 UBA52 RARRES2 CHST2 RPL11	1.98e-05	198	74	5	df681a2308bf75f4d3cef05d7418aabc96116880
ToppCell	10x5'-GI_large-bowel-Lymphocytic_B\|GI_large-bowel / Manually curated celltypes from each tissue	RPL29 BACH2 RUBCNL ZCCHC7 RPL11	1.98e-05	198	74	5	4fac7cdc93dc2037bae41f350b332c30b79c13fb
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature2_(2)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	RPL29 UBA52 RARRES2 CHST2 RPL11	2.02e-05	199	74	5	d946db0e8cc3fbed2d0eb9b4346400138d43219f
ToppCell	COVID-19-Fibroblasts-Pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	RPL29 UBA52 RARRES2 SPON1 RPL11	2.07e-05	200	74	5	73e01b7bc43320a991c67a4fd0c04708f893c7ea
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	BCAM PTPRU EPB41L3 CXADR CACNA2D3	2.07e-05	200	74	5	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	BCAM PTPRU EPB41L3 CXADR CACNA2D3	2.07e-05	200	74	5	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	Control\|World / Disease, condition lineage and cell class	RPL29 ZDHHC1 REPIN1 RPL11 CACNA2D3	2.07e-05	200	74	5	fb10b7fa85bc7d118e481a091645f1f523d29e25
ToppCell	mLN\|World / shred on region, Cell_type, and subtype	RPL29 UBA52 BACH2 ATM RPL11	2.07e-05	200	74	5	9c1617dfde9d9aaa260bbad45b7d0b9caa41e15f
ToppCell	mLN\|World / Region, Cell class and subclass	RPL29 UBA52 BACH2 ATM RPL11	2.07e-05	200	74	5	d8f76374a61db45a689ad2c338d35609629a3199
ToppCell	Control-Neu_1\|World / 5 Neutrophil clusters in COVID-19 patients	RUBCNL SPDYE3 PLXNA4 NLRP1	8.25e-05	138	74	4	b7920c9a28d28220e7e4b30cd91ba13d0548eb76
ToppCell	Control-Myeloid-Dendritic_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RUBCNL NLRP1 CHST2 GMIP	9.47e-05	143	74	4	bb8d4c335682d1a6798bed0de8bb0603054a4944
ToppCell	ASK454-Epithelial-Secretory\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	UVSSA BARD1 CHST2 JMJD1C	9.73e-05	144	74	4	8e693b50bd6c69ce68f44ca6e51f6d0c7f80d82c
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPON1 BACH2 CXXC4 PLXNA4	1.20e-04	152	74	4	621e9b33cd3bb1c7b7d0633069f286b203e3d9c0
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-Teffector/EM_CD4\|GI_small-bowel / Manually curated celltypes from each tissue	PPP1R26 RPL29 UBA52 RPL11	1.32e-04	156	74	4	e308328f560c5ee7e9f95ac5db162f2d821ca39c
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ERCC2 ZNF607 EPB41L3 CACNA2D3	1.36e-04	157	74	4	f896997490bb2eec598c6581f161220e70f9a991
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ERCC2 ZNF607 EPB41L3 CACNA2D3	1.36e-04	157	74	4	14a8516346a89a89f1119b744625bd9844a74a03
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-5\|TCGA-Stomach / Sample_Type by Project: Shred V9	COL2A1 SEPTIN3 BCAM DNMT3B	1.43e-04	159	74	4	c40fe552da3abdb1df87e9e1647468dc038bec0a
ToppCell	severe_influenza-cDC\|World / disease group, cell group and cell class (v2)	SEPTIN3 CXADR CACNA2D3 DNMT3B	1.50e-04	161	74	4	802f8cafb5f499e3b2ec0193d6eb1ac9320b9287
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL2A1 PPP1R26 BRINP2 P3H4	1.50e-04	161	74	4	9703b7e67d9fadb6129cad166bd01be915042e44
ToppCell	390C-Myeloid-Dendritic-cDC_proliferating_2\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	GIMAP8 NR1H3 NDP KIF2C	1.53e-04	162	74	4	a957c7e347189b72fbd47db3075bb5e879a21c67
ToppCell	367C-Myeloid-Monocyte-CD16+_Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	KDM3A RUBCNL KAT6A TET3	1.61e-04	164	74	4	1aff83fc73b4e41e6f0d4b04dbca153bcc7a3518
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL2A1 SEPTIN3 PSAPL1 GFRA2	1.64e-04	165	74	4	0edd56e8d14eaeced9882dd9206ea93e8f402e8d
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL2A1 SEPTIN3 PSAPL1 GFRA2	1.64e-04	165	74	4	fa3aadfff6fb1e7f142db333c60c2cba02b17e6c
ToppCell	356C-Myeloid-Macrophage-SPP1+_Macrophage_4\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	GPR155 BEND3 AR CFB	1.68e-04	166	74	4	8d5d09f25e8903d481c2097fed435e69d42ccdb5
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	NYAP1 AR CACNA2D3 PGR	1.72e-04	167	74	4	9efb9511a211d0824bb97f82c1a5860c43d2138f
ToppCell	Cerebellum-Neuronal-Inhibitory\|Cerebellum / BrainAtlas - Mouse McCarroll V32	NYAP1 AR CACNA2D3 PGR	1.72e-04	167	74	4	904c613aac3f9919a432b110bb1dcc832b5aec0a
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPR155 BACH2 RUBCNL NLRP1	1.76e-04	168	74	4	eeb381b62c7ba263af96de1194ed59e57b6ca3ae
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPR155 BACH2 RUBCNL NLRP1	1.76e-04	168	74	4	063d0368d656962b335154c230bdcd9236e7c9ad
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_B\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPR155 BACH2 RUBCNL NLRP1	1.76e-04	168	74	4	a7c4251d8a83bc30196a444028a35c17c24dc291
ToppCell	BL-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PPP1R26 RARRES2 AR CACNA2D3	1.84e-04	170	74	4	b465df2dac6b4e98b4ede6ad0c6347656757885c
ToppCell	LAM-Lymphoid-B-cell-1\|LAM / Condition, Lineage and Cell class	RPL29 BACH2 RUBCNL RPL11	1.84e-04	170	74	4	2b822a95a8d7ee193d40231418d6bd4cf9662842
ToppCell	control\|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	UBA52 RUBCNL NLRP1 CACNA2D3	1.88e-04	171	74	4	837c1186504f110ccf5b580d9cd4e50ca60c173f
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RARRES2 P3H4 CXADR CFB	1.93e-04	172	74	4	9a256db817c1af1802203cc88a55d608fb328c63
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	SEPTIN3 RUBCNL PLEKHM3 REPIN1	1.93e-04	172	74	4	1215f61f115b042f84721b64c2ed1f48081535f1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RPL29 UBA52 RARRES2 RPL11	1.97e-04	173	74	4	5bb11f9ef17213c9b99fdf92b444f5da3b25fc95
ToppCell	10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages\|bone_marrow / Manually curated celltypes from each tissue	PPP1R26 NR1H3 EPB41L3 GFRA2	2.01e-04	174	74	4	0746344d62aa7ab77c378e9d5a9f9238e741a76b
ToppCell	facs-Spleen-nan-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCND1 CHST2 RINL AR	2.01e-04	174	74	4	096bc6f1889f2bbadfe1e1a3eb6ae569aaa2ee7d
ToppCell	BAL-Control-cDC_11\|Control / Compartment, Disease Groups and Clusters	SEPTIN3 RUBCNL SPDYE3 PTPRU	2.06e-04	175	74	4	daf014e15a354956e9149c83fd89d0af0d07eb00
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL2A1 ADAMTS19 REPIN1 AXIN2	2.06e-04	175	74	4	0431897d7fcc9cefb516cd36987cf18b7f19a26a
ToppCell	(1)_B_cell-(100)_CD19+_Naive_B_cell\|(1)_B_cell / immune cells in Peripheral Blood (logTPM normalization)	RPL29 UBA52 BACH2 RPL11	2.10e-04	176	74	4	08bf8485422fce1a4a3b1e7f6b9fab735ce61d46
ToppCell	droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SEPTIN3 BARD1 NLRP1 KIF2C	2.10e-04	176	74	4	581045e61cdcdfa85701343d1a7c0a72a36606a7
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-RGCs_early_1\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	RPL29 UBA52 SP5 RPL11	2.10e-04	176	74	4	2a15437c5f5dbf6398d5ea70050632c24a7dc66c
Drug	Drospirenone	NR3C2 AR PGR	3.43e-08	3	75	3	DB01395
Drug	mexrenone	NR3C2 AR PGR	3.43e-08	3	75	3	CID003082529
Drug	dienogest	RALA NR3C2 AR PGR	4.05e-07	19	75	4	CID000068861
Drug	3',5'-dichloro-2-hydroxy-2-methylbut-3-enanilide	NR3C2 AR PGR	6.82e-07	6	75	3	ctd:C101850
Drug	Mifepristone	COL2A1 DKK1 SPON1 NR3C2 NDP EPB41L3 AR CXADR CFB PGR AXIN2	1.89e-06	553	75	11	ctd:D015735
Drug	mespirenone	NR3C2 AR PGR	1.90e-06	8	75	3	CID000065660
Drug	sterone-ring	NR3C2 AR PGR	5.56e-06	11	75	3	CID000001108
Drug	3,4,3',4'-tetrachloroazobenzene	NR3C2 AR PGR	5.56e-06	11	75	3	ctd:C013279
Drug	drospirenone	COL2A1 NR3C2 AR PGR	6.60e-06	37	75	4	CID000068873
Drug	Triamcinolone	NR3C2 AR PGR	7.39e-06	12	75	3	ctd:D014221
Drug	19-nor-P	NR3C2 AR PGR	9.59e-06	13	75	3	CID000095585
Drug	Spironolactone	NR3C2 AR	1.07e-05	2	75	2	DB00421
Drug	Methyltrienolone	AR PGR	1.07e-05	2	75	2	DB02998
Drug	spirorenone	NR3C2 AR	1.07e-05	2	75	2	CID000068923
Drug	AC1L1IKP	AR PGR	1.07e-05	2	75	2	CID000004620
Drug	prorenoate	NR3C2 AR	1.07e-05	2	75	2	CID000162581
Drug	latoconazole	AR PGR	1.07e-05	2	75	2	ctd:C072774
Drug	7alpha,11beta-dimethyl-19-nortestosterone	AR PGR	1.07e-05	2	75	2	ctd:C501167
Drug	etoposide phosphate	AR PGR	1.07e-05	2	75	2	ctd:C061400
Drug	NSC9565	NR3C2 AR PGR	1.22e-05	14	75	3	CID000003288
Drug	drospirenone	NR3C2 AR PGR	1.52e-05	15	75	3	ctd:C035144
Drug	C19H22O2	ATM AR PGR	2.26e-05	17	75	3	CID000104880
Drug	ZK112993	NR3C2 AR PGR	2.70e-05	18	75	3	CID000121874
Drug	Alcohol, 8	NR3C2 PGR	3.21e-05	3	75	2	CID011213029
Drug	Methyl ether, 9	NR3C2 PGR	3.21e-05	3	75	2	CID011155441
Drug	1,2,4-trinitrobenzene	NLRP1 BCAM	3.21e-05	3	75	2	CID000123076
Drug	secondary alcohol, 15	NR3C2 PGR	3.21e-05	3	75	2	CID011752649
Drug	Fludrocortisone	NR3C2 AR	3.21e-05	3	75	2	DB00687
Drug	Loteprednol Etabonate	AR PGR	3.21e-05	3	75	2	ctd:D000069559
Drug	Oxime, 22	NR3C2 PGR	3.21e-05	3	75	2	CID011282904
Drug	versalide	AR PGR	3.21e-05	3	75	2	ctd:C023054
Drug	irilone	AR PGR	3.21e-05	3	75	2	ctd:C530234
Drug	prorenone	NR3C2 PGR	3.21e-05	3	75	2	CID000170819
Drug	Danazol	AR CFB PGR	3.76e-05	20	75	3	ctd:D003613
Drug	1,2-dimethylhydrazine dihydrochloride	COL2A1 AR PGR	3.76e-05	20	75	3	CID000009380
Drug	Teniposide	NR1H3 AR PGR	4.38e-05	21	75	3	ctd:D013713
Drug	(-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A	LIG3 GLG1 KAT6A KDM2A BCAM AR	4.90e-05	198	75	6	5533_DN
Drug	4ma Compound	ATM AR PGR	5.05e-05	22	75	3	CID000052099
Drug	Fluticasone Propionate	NR3C2 PGR	6.40e-05	4	75	2	DB00588
Drug	laurolactam	AR PGR	6.40e-05	4	75	2	ctd:C474694
Drug	Levonorgestrel	AR PGR	6.40e-05	4	75	2	DB00367
Drug	Progesterone	NR3C2 PGR	6.40e-05	4	75	2	DB00396
Drug	Oseltamivir	AR PGR	6.40e-05	4	75	2	ctd:D053139
Drug	phantolid	AR PGR	6.40e-05	4	75	2	ctd:C033117
Drug	ciclesonide	AR PGR	6.40e-05	4	75	2	ctd:C120481
Drug	beta-estradiol 3-benzoate	COL2A1 KCND1 ATM AR PGR	6.54e-05	128	75	5	CID000003262
Drug	nomegestrol acetate	NR3C2 AR PGR	7.49e-05	25	75	3	CID000091668
Drug	un-t	NR1H3 NR3C2 BCAM	8.45e-05	26	75	3	CID000031192
Drug	Norethindrone	NR3C2 AR PGR	9.49e-05	27	75	3	ctd:D009640
Drug	14-HRR	RALA AR	1.06e-04	5	75	2	CID006438154
Drug	6-methylene progesterone	AR PGR	1.06e-04	5	75	2	CID000119075
Drug	isobutylparaben	AR PGR	1.06e-04	5	75	2	ctd:C471067
Drug	3-benzylidene camphor	AR PGR	1.06e-04	5	75	2	ctd:C511303
Drug	Emd 23448	NLRP1 BCAM	1.06e-04	5	75	2	CID000126443
Drug	zindoxifene	AR PGR	1.06e-04	5	75	2	CID000065645
Drug	3',5'-dichloro-2-hydroxy-2-methylbut-3-enanilide	AR PGR	1.06e-04	5	75	2	CID000115209
Drug	homosalate	AR PGR	1.06e-04	5	75	2	ctd:C060446
Drug	CDRI-85/287	NR3C2 AR PGR	1.18e-04	29	75	3	CID000159508
Drug	vorozole	NR3C2 ATM PGR	1.31e-04	30	75	3	CID000060796
Drug	DHTP	ATM BCAM AR	1.44e-04	31	75	3	CID000013328
Drug	N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide	ATM AR PGR	1.59e-04	32	75	3	ctd:C451426
Drug	AC1L9KJW	AR PGR	1.59e-04	6	75	2	CID000447173
Drug	Danazol	AR PGR	1.59e-04	6	75	2	DB01406
Drug	AC1L4O7F	AR PGR	1.59e-04	6	75	2	CID000160762
Drug	2,6-di-tert-butyl-4-hydroxy-4-methyl-2,5-cyclohexadien-1-one	AR PGR	1.59e-04	6	75	2	ctd:C038639
Drug	3,5-di-tert-butyl-4-hydroxybenzaldehyde	AR PGR	1.59e-04	6	75	2	ctd:C513957
Drug	CDP-ribitol	NLRP1 BCAM	1.59e-04	6	75	2	CID000165130
Drug	Dmnt	AR PGR	1.59e-04	6	75	2	CID000092248
Drug	(3-(4-(bis(2-chloroethyl)amino)phenyl)-3-propyl)carbamic acid 2-(6-(17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-11-yl)hexylamino)ethyl ester	AR PGR	1.59e-04	6	75	2	ctd:C513485
Drug	butylparaben	COL2A1 NR3C2 AR CACNA2D3 PGR	1.71e-04	157	75	5	ctd:C038091
Drug	trimegestone	NR3C2 AR PGR	1.74e-04	33	75	3	CID000068926
Drug	exemestane	RNF123 AR PGR	2.08e-04	35	75	3	ctd:C056516
Drug	5'-CAT	ATM AR	2.22e-04	7	75	2	CID000100652
Drug	T 47	NLRP1 PGR	2.22e-04	7	75	2	CID000134566
Drug	2,2-di(4-methacryloxyphenyl)propane	AR PGR	2.22e-04	7	75	2	ctd:C002462
Drug	D 1939	RALA AR	2.22e-04	7	75	2	CID000075575
Drug	octyldimethyl-p-aminobenzoic acid	AR PGR	2.22e-04	7	75	2	CID000042851
Drug	Cortodoxone	NR3C2 AR	2.22e-04	7	75	2	ctd:D003350
Drug	ethyl myristate	AR PGR	2.22e-04	7	75	2	ctd:C032396
Drug	Medroxyprogesterone	AR PGR	2.22e-04	7	75	2	ctd:D008525
Drug	lead thiocyanate	AR PGR	2.22e-04	7	75	2	CID000011616
Drug	A 5791	ATM AR PGR	2.46e-04	37	75	3	CID000003408
Drug	promegestone	NR3C2 AR PGR	2.46e-04	37	75	3	CID000036709
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	BACH2 RUBCNL BRINP2 NLRP1 DNMT3B	2.54e-04	171	75	5	4237_UP
Drug	2,6-dihydroxybenzoic acid	NR3C2 REPIN1 AR CXADR PGR	2.83e-04	175	75	5	CID000009338
Drug	AC1L1HMM	COL2A1 BARD1 NR3C2 EPB41L3 AR CXADR PGR AXIN2	2.94e-04	516	75	8	CID000004196
Drug	DDOH	AR PGR	2.96e-04	8	75	2	CID000017533
Drug	propylparaben	ATM AR PGR	3.11e-04	40	75	3	ctd:C006068
Disease	lung small cell carcinoma (is_implicated_in)	ATM AXIN2 DNMT3B	4.55e-05	28	73	3	DOID:5409 (is_implicated_in)
Disease	oral squamous cell carcinoma (is_implicated_in)	BRINP2 AXIN2 DNMT3B	4.55e-05	28	73	3	DOID:0050866 (is_implicated_in)
Disease	oral mucosa leukoplakia (is_marker_for)	ATM AXIN2	9.00e-05	6	73	2	DOID:9655 (is_marker_for)
Disease	neutrophil percentage of leukocytes	COL2A1 PHF23 GLG1 BEND3 NR3C2 GMIP JMJD1C CFB	1.32e-04	610	73	8	EFO_0007990
Disease	Prostatic Neoplasms	ERCC2 MBD1 KAT6A SP5 ATM AR RPL11 DNMT3B	1.41e-04	616	73	8	C0033578
Disease	Malignant neoplasm of prostate	ERCC2 MBD1 KAT6A SP5 ATM AR RPL11 DNMT3B	1.41e-04	616	73	8	C0376358
Disease	Dickkopf-related protein 4 measurement	DKK1 JMJD1C	1.67e-04	8	73	2	EFO_0008110
Disease	Cardiomyopathy, Dilated	NR3C2 ATM AXIN2	2.32e-04	48	73	3	C0007193
Disease	lymphocyte count	COL2A1 SEPTIN3 GIMAP8 PHF23 BACH2 BEND3 NR3C2 ATM CHST2 JMJD1C GFRA2 DNMT3B	2.36e-04	1464	73	12	EFO_0004587
Disease	lymphocyte percentage of leukocytes	PHF23 BACH2 BEND3 NR1H3 NR3C2 GMIP JMJD1C DNMT3B	2.36e-04	665	73	8	EFO_0007993
Disease	Cardiomyopathy, Familial Idiopathic	NR3C2 ATM AXIN2	2.62e-04	50	73	3	C1449563
Disease	Mammary Carcinoma, Human	DKK1 BARD1 ATM EPB41L3 AR PGR DNMT3B	3.21e-04	525	73	7	C4704874
Disease	Mammary Neoplasms, Human	DKK1 BARD1 ATM EPB41L3 AR PGR DNMT3B	3.21e-04	525	73	7	C1257931
Disease	senile cataract (is_implicated_in)	ERCC2 ATM	3.27e-04	11	73	2	DOID:9669 (is_implicated_in)
Disease	endometrial carcinoma, endometriosis	PGR AXIN2	3.27e-04	11	73	2	EFO_0001065, EFO_1001512
Disease	Mammary Neoplasms	DKK1 BARD1 ATM EPB41L3 AR PGR DNMT3B	3.28e-04	527	73	7	C1458155
Disease	Breast Carcinoma	DKK1 BARD1 ATM EPB41L3 AR PGR DNMT3B	3.71e-04	538	73	7	C0678222
Disease	dickkopf‐related protein 1 measurement	DKK1 JMJD1C	3.92e-04	12	73	2	EFO_0010620
Disease	PROSTATE CANCER, HEREDITARY, 1	KDM2A ATM DNMT3B	4.49e-04	60	73	3	C4722327
Disease	colon carcinoma (is_marker_for)	UBA52 AXIN2	4.63e-04	13	73	2	DOID:1520 (is_marker_for)
Disease	oral squamous cell carcinoma (is_marker_for)	ATM AXIN2 DNMT3B	5.19e-04	63	73	3	DOID:0050866 (is_marker_for)
Disease	Neoplasm of uncertain or unknown behavior of bladder	ERCC2 ATM	6.21e-04	15	73	2	C0496930
Disease	lateral ventricle volume change measurement	EPB41L3 GFRA2	6.21e-04	15	73	2	EFO_0021502
Disease	Benign neoplasm of bladder	ERCC2 ATM	6.21e-04	15	73	2	C0154017
Disease	Carcinoma in situ of bladder	ERCC2 ATM	6.21e-04	15	73	2	C0154091
Disease	Prostate cancer, familial	KDM2A ATM DNMT3B	6.77e-04	69	73	3	C2931456
Disease	Benign neoplasm of stomach	ATM AXIN2	8.02e-04	17	73	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	ATM AXIN2	8.02e-04	17	73	2	C0496905
Disease	Carcinoma in situ of stomach	ATM AXIN2	8.02e-04	17	73	2	C0154060
Disease	esophagus squamous cell carcinoma (is_marker_for)	ATM TET3 DNMT3B	8.30e-04	74	73	3	DOID:3748 (is_marker_for)
Disease	Stomach Neoplasms	ERCC2 BOP1 ATM AXIN2 DNMT3B	8.58e-04	297	73	5	C0038356
Disease	Malignant neoplasm of stomach	ERCC2 BOP1 ATM AXIN2 DNMT3B	8.97e-04	300	73	5	C0024623
Disease	Carcinoma of bladder	ERCC2 ATM	9.00e-04	18	73	2	C0699885
Disease	nicotine dependence	GFRA2 CACNA2D3 DNMT3B	9.67e-04	78	73	3	EFO_0003768
Disease	Hereditary Non-Polyposis Colon Cancer Type 2	BARD1 ATM	1.00e-03	19	73	2	C1333991
Disease	Colorectal cancer, hereditary nonpolyposis, type 1	BARD1 ATM	1.00e-03	19	73	2	C2936783
Disease	Adenocarcinoma of prostate	ATM AR	1.11e-03	20	73	2	C0007112
Disease	acute myeloid leukemia (is_implicated_in)	ERCC2 KAT6A DNMT3B	1.20e-03	84	73	3	DOID:9119 (is_implicated_in)
Disease	gestational age, birth measurement	COL2A1 CACNA2D3	1.23e-03	21	73	2	EFO_0005112, EFO_0006921
Disease	polycystic ovary syndrome (biomarker_via_orthology)	RARRES2 PGR	1.23e-03	21	73	2	DOID:11612 (biomarker_via_orthology)
Disease	BREAST CANCER	BARD1 ATM	1.23e-03	21	73	2	114480
Disease	Stomach Carcinoma	ATM AXIN2	1.23e-03	21	73	2	C0699791
Disease	Malignant neoplasm of breast	ADAMTS19 KDM3A DKK1 BARD1 ATM EPB41L3 AR PGR DNMT3B	1.30e-03	1074	73	9	C0006142
Disease	Immunologic Deficiency Syndromes	ATM DNMT3B	1.48e-03	23	73	2	C0021051
Disease	obesity (is_implicated_in)	NR1H3 AR PGR	1.51e-03	91	73	3	DOID:9970 (is_implicated_in)
Disease	Pseudoaphakia	COL2A1 ATM	1.61e-03	24	73	2	C0524524
Disease	Lens Opacities	COL2A1 ATM	1.61e-03	24	73	2	C1510497
Disease	atrophic macular degeneration	BARD1 CFB	1.75e-03	25	73	2	EFO_1001492
Disease	Hereditary Nonpolyposis Colorectal Neoplasms	BARD1 ATM	1.89e-03	26	73	2	C0009405
Disease	Adenoid Cystic Carcinoma	KAT6A ATM JMJD1C	1.98e-03	100	73	3	C0010606
Disease	Hereditary non-polyposis colorectal cancer syndrome	BARD1 ATM	2.04e-03	27	73	2	C1112155
Disease	Malignant tumor of breast	BARD1 ATM	2.04e-03	27	73	2	cv:C0006142
Disease	Breast neoplasm	BARD1 ATM	2.04e-03	27	73	2	cv:C1458155
Disease	macular degeneration (is_implicated_in)	ERCC2 CFB	2.04e-03	27	73	2	DOID:4448 (is_implicated_in)
Disease	Familial cancer of breast	BARD1 ATM	2.04e-03	27	73	2	cv:C0346153
Disease	retinal degeneration (biomarker_via_orthology)	BARD1 CFB	2.19e-03	28	73	2	DOID:8466 (biomarker_via_orthology)
Disease	free cholesterol measurement, intermediate density lipoprotein measurement	MACO1 BCAM JMJD1C	2.21e-03	104	73	3	EFO_0008591, EFO_0008595
Disease	Hereditary Nonpolyposis Colorectal Cancer	BARD1 ATM	2.35e-03	29	73	2	C1333990

Protein segments in the cluster

Peptide	Gene	Start	Entry
RCLDLYLCPRQRKMR	BOP1	366	Q14137
NRIAAQRCRKRKLDC	BACH2	656	Q9BYV9
KLLRCSRCTNILREP	BARD1	46	Q99728
RGRRIKKCATQLCRR	CATSPERD	751	Q86XM0
MCLPQRCHGVLRRRK	DNMT3B	526	Q9UBC3
CRRLAEVSKPPKQRC	AXIN2	701	Q9Y2T1
RKNPARTCRDLKLCH	COL2A1	1276	P02458
KRKSLAKRIRERCCI	RALA	191	P11233
CPRCARITARRKLLE	RUBCNL	641	Q9H714
ECKVRPNGRKRKCLA	RARRES2	86	Q99969
IRHRTVRCTNPRKKC	ADAMTS19	1056	Q8TE59
MRRKCQECRLRKCRQ	NR1H3	146	Q13133
DERCRRPNRKKCDIL	BEND3	806	Q5T5X7
KTVRKAECRAIHCPR	CFB	91	P00751
SCCPRRAKRRAIRLA	KCND1	531	Q9NSA2
IIDKIRRKNCPACRL	NR3C2	646	P08235
LRRLRGPAKCRECEA	GMIP	496	Q9P107
LCIRNIVKERRCGAK	GPR155	761	Q7Z3F1
PNLQKCRECRLIRSK	JMJD1C	1726	Q15652
CRECRLIRSKKGEEP	JMJD1C	1731	Q15652
KCVQRRCLRGKHARR	MBD1	256	Q9UIS9
ADCSKLRRPLKRNRI	MACO1	6	Q8N5G2
CTRKERCERSKEPRR	PLXNA4	536	Q9HCM2
KSLCKTLRRPRCLLE	NLRP1	826	Q9C000
CIQRKPLRFCAERLR	ERCC2	366	P18074
KFRRKNCPSCRLRKC	AR	606	P10275
KEKSVPCPRCVRREL	PLEKHM3	716	Q6ZWE6
PCPRCVRRELQKKQK	PLEKHM3	721	Q6ZWE6
PRHKDCLLREFRKLC	LIG3	256	P49916
ARLHPRAVNCRKKKC	UBA52	101	P62987
TRLNCIRIARKAACK	PTPRU	716	Q92729
RNDCIVDKIRRKNCP	PGR	606	P06401
VDKIRRKNCPACRLR	PGR	611	P06401
EHRICVCVRKRPLNK	KIF2A	221	O00139
ICQICRPRKKGRKLL	KAT6A	306	Q92794
RVRLQPECKKRLNDR	GLG1	1101	Q92896
KCANRRAPRLKCQEL	ATM	106	Q13315
RRRVRCRKCKACVQG	KDM2A	566	Q9Y2K7
AQLPKCRECRLDSLR	KDM3A	541	Q9Y4C1
PTERCNRRKCHKALR	GFRA2	191	O00451
ERLKAQKIRRRPESC	CACNA2D3	1041	Q8IZS8
ALIGLIIFCCRKKRR	CXADR	251	P78310
ALRRIFKKCGRRVCA	GIMAP8	586	Q8ND71
RKRCGVCVPCKRLIN	CXXC4	136	Q9H2H0
RKRECQLVRGACKPE	DEFB113	31	Q30KQ7
VRRKGGPCCRQRREK	BCAM	571	P50895
AGVQICLACRKRRKR	DKK1	106	O94907
EHRICVCVRKRPLNK	KIF2C	256	Q99661
TELRRRCKENDCKLP	EPB41L3	526	Q9Y2J2
KRCVCKEIKARHRPD	NYAP1	786	Q6ZVC0
KRARARIAKGLRLCR	RPL29	106	P47914
CPETVQRKKCRIRKC	SPON1	706	Q9HCB6
QRKKCRIRKCLRNPS	SPON1	711	Q9HCB6
RIRKCLRNPSIQKLR	SPON1	716	Q9HCB6
PEKVCKFIRLCGNRR	PSAPL1	356	Q6NUJ1
RPDGRLCERQDRLKC	UVSSA	571	Q2YD98
KAPLAATARRCRRCR	SP5	261	Q6BEB4
KLKKRCREPRAACRK	PPP1R26	706	Q5T8A7
CREPRAACRKKVRFS	PPP1R26	711	Q5T8A7
CPVTCDKRKRLLRDQ	TECTB	276	Q96PL2
ACPKCERRFWRRKQL	REPIN1	146	Q9BWE0
LCKRCHRQPRFRLPK	BRINP2	396	Q9C0B6
DDRVCKKCPPQRLAR	CHST2	276	Q9Y4C5
CAPRRKVALLLEVCR	RINL	421	Q6ZS11
RRVPQRKEVSRCRKC	SHFL	121	Q9NUL5
CGRICRDIPKGRKRD	WFDC3	61	Q8IUB2
GRKRDCPRVIRKQSC	WFDC3	71	Q8IUB2
CPRVIRKQSCLKRCI	WFDC3	76	Q8IUB2
PMRELRIRKLCLNIC	RPL11	11	P62913
FLDCRSRPQCRVKVK	SPIDR	836	Q14159
ARKKRIPDTRVHCCL	SEPTIN3	161	Q9UH03
RRCPKRRKDILAELT	RNF123	791	Q5XPI4
PRRSLGCKRKRECLD	SPDYE3	336	A6NKU9
RKRRFQLCRCMNPRA	SPDYE7P	141	Q495Y7
ERAACLRRCKRTLPA	P3H4	111	Q92791
KPFKCNKCRRSFRLR	ZNF607	671	Q96SK3
RKKRKRCGTCEPCRR	TET3	51	O43151
CQKCKELRPEARRLG	PHF23	381	Q9BUL5
CRPQTSKLKALRLRC	NDP	96	Q00604
HLSKNCPLPRKVRRC	ZCCHC7	251	Q8N3Z6
ICRDFLRNVCKRGKR	ZC3H10	41	Q96K80
CSCPQKKRHIDLRRP	ZAR1L	281	A6NP61
DLRRPHRQELCGRCK	ZAR1L	291	A6NP61
KRGRGACIKCERLRP	ZDHHC1	391	Q8WTX9